STADAPHARM GmbH
Location
Hessen
Founded
1993-02-24
Website
Risk Signals
605 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, In Vitro and In Vivo Diagnostic Substances, Patent Owners and Lessors, Business Services, Not Elsewhere Classified, Engineering Services, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about STADAPHARM GmbH
Live alerts from global media, monitored by Business Radar
2025-06-03 (handelsblatt.com)
Pharmaceutical manufacturers: Stada owners apparently negotiate with two prospective buyers
According to a report, the pharmaceutical company could be sold as a whole. If the negotiations do not lead to success, the Stada owners hold ...
Read more
2025-03-25 (mein-geld-medien.de)
New deals and fresh money in the health market - investor magazine my money
The possible stock exchange tours of Stada, Hingse Health and other healthcare companies make headlines at the same time, the industry is facing a new wave of takeover. What is behind the many IPOS and M&A? This is analyzing the Healthcare and Biotech Fund Manager from APO Asset Management and Medical Strategy. More IPOs in the health sector A growing number of healthcare companies is planning this year […]
Read more
2025-03-03 (boersen-zeitung.de)
Can the returns be saved in the Large Cap Private Equity? |
Thomas Weinmann made the first billion dollar deal in Germany for BC Partners. Today he relies on small transactions with Reia Capital.
Read more
2025-03-03 (boersen-zeitung.de)
Can the returns be saved in the Large Cap Private Equity? |
Thomas Weinmann made the first billion dollar deal in Germany for BC Partners. Today he relies on small transactions with Reia Capital.
Read more
2025-01-10 (finance-magazin.de)
M&A-Deals: XXXLutz, Stada, Rheinmetall
XXXLutz swallows Porta, Stada is considering an IPO and Rheinmetall is strengthening its software business: The M&A deals of the week in the FINANCE review.
Read more
2025-01-09 (faz.net)
Pharmaceutical company from Bad Vilbel: Stada is aiming for an IPO
In 2018, the financial investors Bain and Cinven took Stada off the stock exchange after the takeover. Now the pharmaceutical company is set to return to the trading floor – possibly very soon.
Read more
2025-01-09 (faz.net)
Pharmaceutical company from Bad Vilbel: Stada is aiming for an IPO
In 2018, the financial investors Bain and Cinven took Stada off the stock exchange after the takeover. Now the pharmaceutical company is set to return to the trading floor – possibly very soon.
Read more
2025-01-09 (faz.net)
Pharmaceutical company from Bad Vilbel: Stada is aiming for an IPO
In 2018, the financial investors Bain and Cinven took Stada off the stock exchange after the takeover. Now the pharmaceutical company is set to return to the trading floor – possibly very soon.
Read more
2024-11-12 (deutsche-apotheker-zeitung.de)
Shareholders' Association SdK is promoting a class action lawsuit against Stada
Numerous pharmacists and other former shareholders of the pharmaceutical manufacturer Stada can hope for additional money from an earlier takeover offer. This is the view of the shareholders' association Schutzgemeinschaft der Kapitalanleger (SdK), which is seeking a class action lawsuit and, among other things, for this
Read more
2024-11-12 (deutsche-apotheker-zeitung.de)
Shareholders' Association SdK is promoting a class action lawsuit against Stada
Numerous pharmacists and other former shareholders of the pharmaceutical manufacturer Stada can hope for additional money from an earlier takeover offer. This is the view of the shareholders' association Schutzgemeinschaft der Kapitalanleger (SdK), which is seeking a class action lawsuit and, among other things, for this
Read more
2024-09-23 (focus.de)
Schenker in 4th place: These are the most expensive sales by German companies
With Schenker, the logistics division of Deutsche Bahn, another German company is being sold to a foreign competitor. With 14 billion euros, Schenker joins an illustrious list.
Read more
2024-09-23 (focus.de)
Schenker in 4th place: These are the most expensive sales by German companies
With Schenker, the logistics division of Deutsche Bahn, another German company is being sold to a foreign competitor. With 14 billion euros, Schenker joins an illustrious list.
Read more